packageNeostigmine

neostigmine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Neostigmine is an acetylcholinesterase inhibitor used for conditions such as myasthenia gravis and urinary retention, and also as an antiglaucoma eye preparation. It is an approved medicine, including veterinary use, and is listed among WHO essential medicines, so it remains widely available.

Summary written by glm-5.3-flash from Wikidata Q410546 and the WHO ATC classification; not checked by a person.

name:neostigmine
ATC codes:N07AA01, S01EB06
DrugBank:DB01400
PubChem CID:4456
ChEBI:7514
Wikidata:Q410546
formula:C12H19N2O2+
molar mass:223.296 g/mol (PubChem CID 4456)
logP:1.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown